Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient

• Status: Not yet recruiting
• Trial end date: 2024-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

this study is designed to compare the Progesterone primed ovarian stimulation protocol versus the antagonist protocol as a method to stimulate PCO patients in ICSI cycles to decrease cost and decrease OHSS.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Fayoum University
• Treatments: Cetrorelix; Dydrogesterone; Progesterone

Criteria

Inclusion Criteria:

• 1. PCO patients based on Rotterdam criteria (2003), including polycystic ovaries, oligo-anovulation, as well as the biochemical or clinical signs of hyperandrogenism (Rotterdam et al, 2003).

2. Age less than 40 years old. 3. Primary infertility for 2 years and secondary infertility for 1 year.

Exclusion Criteria:

• Non-PCO patients as:

• Congenital adrenal hyperplasia

• Hyperprolactinemia.

• Recurrent implantation failure.

• Hydrosalpinx.

• Uterine pathology.

• Uncontrolled medical disorder eg DM, HTN

• Male factor infertility.